(+34) 951 419 212
Ovoclinic-Ovobank actively participated in the ASEBIR National Congress 2025 held in Barcelona, where they presented two studies providing new scientific evidence in the field of assisted reproduction and, in particular, in egg donation treatments.
The first of the two communications addresses the implementation and validation of a universal protocol for oocyte devitrification, designed to work effectively with different commercial vitrification systems. The results show that this procedure maintains high survival rates and adequate embryo development, representing an important step toward unifying criteria in laboratories and achieving more versatile management of donated oocytes.
The second study presented analyzes one of the most debated topics in clinical practice: the impact of donor and recipient age on pregnancy rates. After evaluating a large number of egg donation cycles, the data confirm that, within the usual age ranges used for selecting donors and recipients, no significant differences are detected in reproductive outcomes. This finding reinforces the reliability of the selection process and provides greater reassurance to patients.
“For us, each scientific advancement has a direct impact on the families we support,” the Ovoclinic-Ovobank team highlights. “Events like ASEBIR are essential for continuing to grow as a scientific community and for continuously improving protocols,” adds Enrique Criado, embryologist and CEO of Ovoclinic-Ovobank.
With its presence at ASEBIR 2025, Ovoclinic-Ovobank reaffirms its commitment to applied research, technical excellence, and the ongoing pursuit of improvements that translate into more effective and personalized treatments for those who trust in assisted reproduction.
